WHO Issues Alert Over Acute Lack of Obesity Jabs
Fewer than one in 10 patients who could benefit from weight-loss injections including Wegovy can access them, warns the World Health Organization as it issues its first guidance on the drugs.
With more than one billion individuals worldwide currently classified as obese, it is advocating for broader and more equitable availability to this class of drugs.
Per estimates, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"Our new guidance acknowledges that obesity is a chronic disease that can be managed with comprehensive and lifelong support," remarked its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and logistical bottlenecks are key hurdles to universal access to the injections that can aid individuals in losing substantial body mass, explains the body.
GLP-1 Therapy Supply Crisis
Despite the present most favorable outlook, the supply of these medications would only suffice for approximately 100 million people – less than 10% of eligible patients, according to the health organization.
The guideline urges governments and firms to expand access, through measures such as voluntary licensing.
The intellectual property rights on a key compound – the core component of the drug Wegovy – is due to expire in multiple countries in 2026.
How Weight-Loss Jabs Operate
These medications mimick a biological compound to slow digestion, curb appetite and increase feelings of fullness so individuals reduce food intake.
Individuals typically see weight reduction within a few weeks of starting on the weekly injections.
Research suggests patients may regain a significant portion after a year of discontinuing the medication, as their usual hunger resume.
To be overweight or obese elevates your risk for experiencing diseases, like type 2 diabetes, cardiovascular issues, brain attack, and some cancers.
Obesity impacts people in every country and was linked to millions of fatalities worldwide in 2024, as per the health agency.
